Literature DB >> 8601113

Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study.

K R Neal1, H M Scott, R C Slack, R F Logan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8601113      PMCID： PMC2350063          DOI： 10.1136/bmj.312.7028.414

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection.

Authors:  K R Neal; S O Briji; R C Slack; C J Hawkey; R F Logan
Journal:  BMJ       Date:  1994-01-15

2.  Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro.

Authors:  R A Giannella; S A Broitman; N Zamcheck
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

3.  The relationship between infecting dose and severity of disease in reported outbreaks of Salmonella infections.

Authors:  J R Glynn; D J Bradley
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451
  3 in total
  31 in total

1.  The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Authors:  R M Martin; N R Dunn; S Freemantle; S Shakir
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

Review 2.  Prevention and self-treatment of traveler's diarrhea.

Authors:  David J Diemert
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

3.  Inappropriate prescribing of proton pump inhibitors in primary care.

Authors:  Bisanth Thushila Batuwitage; Jeremy G C Kingham; Nia Emma Morgan; Ruth Louise Bartlett
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

4.  Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS.

Authors:  David Law; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

5.  The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England.

Authors:  Lynda V Wilton; Cheryl Key; Saad A W Shakir
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Travellers' diarrhea in children.

Authors:  Pierre J Plourde
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

7.  Inhibition of lysosomal enzyme activities by proton pump inhibitors.

Authors:  Wensheng Liu; Susan S Baker; Jonathan Trinidad; Alma L Burlingame; Robert D Baker; John G Forte; Lauren P Virtuoso; Nejat K Egilmez; Lixin Zhu
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

Review 8.  Insights into the future of gastric acid suppression.

Authors:  Kenneth R DeVault; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

Review 9.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 10.  Diagnosis and treatment of acute or persistent diarrhea.

Authors:  Sean W Pawlowski; Cirle Alcantara Warren; Richard Guerrant
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.